Navigation Links
Homeless cells find temporary lodging -- and their demise
Date:11/29/2007

BOSTON, Mass. (Nov. 29, 2007)Sometimes healthy cells commit suicide. In the 1970s, scientists showed that a type of programmed cell death called apoptosis plays a key role in development, and the 2002 Nobel Prize in Physiology or Medicine recognized their work. As apoptotic cells degrade, they display standard characteristics, including irregular bulges in the membrane and nuclear fragmentation.

Now, Harvard Medical School researchers have uncovered a new type of death devoid of these features. In the Nov. 30 issue of Cell, they report a bizarre cell-in-cell invasion and death process, which they name entosis, after the Greek word for within.

We watched homeless cells, free of their normal attachments, bore into their neighbors and die inside compartments called vacuoles, says Michael Overholtzer, a postdoctoral researcher in Joan Brugges lab.

Were not sure if entosis evolved to play a particular role or if its simply an aberration of a normal process, adds Brugge, who is Chair of the Department of Cell Biology.

Overholtzer discovered entosis while working with human breast cells that normally form sheets of tissue. When these cells become detached from their protein-rich beds, they generally die through apoptosis. But Overholtzer noticed that they behave oddly long before displaying apoptotic features. In fact, many of these homeless cells actually nest inside their neighbors.

Further experimentation revealed that the cells actively invade neighboring cells. While some of the intruderswhich initially appear healthylater exit their hosts unharmed, most die inside vacuoles.

But Overholtzer didnt realize the implications of his initial observation until he crossed paths with Brigham and Womens Hospital pathologist Andrea Richardson. She informed him that the scientific literature is full of cell-in-cell references in the context of cancer.

Although these structures have been described by pathologists
'/>"/>

Contact: Alyssa Kneller
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. $8,000 Winning Bids at Governors Livestock Auction to Benefit College-Bound Youth and Homeless
2. United Way of Greater Los Angeles Kicks Off Initiative to Prevent and End Homelessness With HomeWalk 2007
3. The Jericho Project Announces Rehabilitation Residence for Homeless and Low-Income Veterans
4. Homeless Vets - VA Sets the Record Straight
5. New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves
6. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
7. Brain cells work differently than previously thought
8. Embryonic Stem Cells Repair Human Heart
9. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
10. Circulating fats kill transplanted pancreas cells, study shows
11. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...re inequalities may have the most significant impa...cancer (CRC) between African// Americans and Cauca...June 1, 2007 issue of CANCER, a peer-reviewed jour...is of data from published studies demonstrated tha...
... a handful of concerned citizens. Delhi, burning u...h Day Sunday, //by raising its voice on various is... are on the brink of a challenge,' said Ravi Aggar...GO. 'The issue of stopping deforestation and felli...
...ted with an electronic biometric attendance system...l be initially installed in a few primary schools,...state. It would first be installed in 15 schools o...f Dausa. 'Some of the machines have already reach...
...ion drive aimed at protecting millions of children...ealth experts, nearly 10% of the// children could ...f Health is conducting the MMR (measles, mumps and...will be on for two weeks. This is being funded by ...
Other Medicine News:Health News:Social Factors Not Genetics Drive Racial Disparities in Colorectal Cancer Survival 2Health News:Earth Day Celebrated With Hopes of a Greener Tomorrow 2
(Date:9/3/2008)...SELS, Belgium and GENEVA, Sept. 3 /- ...lestone in CHO based monoclonal antibody,productio...over 31 grams,per liter. This record level was acc...logies: (1) a high-performance stable Selexis CHO,... leading scientists at,Selexis SA using their prop...
(Date:9/3/2008)... Company to Discuss Phase 3 Plans with FDA...Therapeutics, Inc.,announced today that it succes...velopment of the company,s new, innovative low-dos...pany refers to by its internal product,code AG-200...sfully met its,primary endpoint of ovulation suppr...
(Date:9/3/2008)...509 to be Evaluated in Repeat-Dosing Study in Subj...ire-FirstCall/ -- Sangamo,BioSciences, Inc. (Nasda...ase,2 clinical trial (SB-509-801) to evaluate its ... degenerative motor-neuron disease for which there...amo,s drug, SB-509, is an injectable formulation o...
(Date:9/2/2008)...S, September 3 /-, - This ...ased the Risk,of Stroke by 34% in Patients With At...tely Treated by Antithrombotic Therapy, The resul...ENA study,were presented today at the clinical tri...ology congress 2008, in Munich, Germany. Previous ...
Breaking Medicine Technology:Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Amira Pharmaceuticals Appoints First Vice President of Development 5214 1Amira Pharmaceuticals Appoints First Vice President of Development 5214 2Agingcare com Launches to Meet Information and Networking Demands for Booming 34 Million Caregiver Market 5211 1Agingcare com Launches to Meet Information and Networking Demands for Booming 34 Million Caregiver Market 5211 2Sigma Aldrich Announces mirPremier 28TM 29 microRNA Isolation Kit for miRNA Purification 5208 1Sigma Aldrich Announces mirPremier 28TM 29 microRNA Isolation Kit for miRNA Purification 5208 2Sigma Aldrich Announces mirPremier 28TM 29 microRNA Isolation Kit for miRNA Purification 5208 3Spinal Stem Cells Offer Hope Against Back Pain 5205 1Spinal Stem Cells Offer Hope Against Back Pain 5205 2
...New Studies Confirm That Fusion Proteins Made by C...dies Demonstrate Increased,Anti-Tumor Activity Wit..., Calif., April 18, 2007,/PRNewswire-FirstCall/ --...e biopharmaceutical company developing targeted,mo...d hepatitis C,virus infection, today reported that...
...AITHERSBURG, Md. and CARLSBAD, Calif., April 18, 2...edImmune, Inc. today,announced data from a preclin...rcinoembryonal antigen (CEA) were shown to prevent...etastases. An,established marker for tumor progres... and other human carcinomas. These data,presented...
Other Medicine Technology:Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 2Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 3Data Presented at AACR Meeting Shows Peregrine's Immunocytokine,Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in,Preclinical Studies 4Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 2Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 3Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 4Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA 5
...ries Freezing Stages fit easily onto most microtom...arts and need only the AC supply and a trickle of ...ediately and can be maintained indefinitely. Stag...g temperatures can be set for different kinds of t...
ELISA kit for the quantitative determination of autoantibodies to glutamic acid decarboxylase (GAD65) in serum
ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum
RIA kit for the quantitative determination of autoantibodies to insulin in serum
Medicine Products: